-SELECTIN IS A cell adhesion molecule expressed by endothelial cells following activation by several inflammatory cytokines.'.' E-selectin is one of a family of adhesion molecules, termed selectins, which contain C-type lectin domains and which share a similar domain structure and function."' E-and P-selectin are both inducibly expressed on endothelial cells lining blood vessels, while Lselectin is constitutively expressed on circulating leukocytes. Unlike P-selectin, which is rapidly mobilized to the cell surface by fusion of specialized storage granules with the plasma membrane, E-selectin surface expression occurs several hours after activation and requires de novo gene transcription and protein ~ynthesis.'.'.~ Binding of E-selectin to its ligand(s) results in leukocyte rolling along the lumenal surface of blood vessels,6 slowing movement enough to allow the secondary, higher affinity interactions involved in arrest of leukocytes on the endothelium. Interaction of selectins with their ligands characteristically shows Ca2+ dependence and sensitivity to neuraminidase treatment. E-selectin binds to ligand(s) present on several populations of leukocytes, including neutrophils, monocytes, eosinophils, basophils, natural killer (NK) cells, and some lymphocyte subpopulation~.~~'~~ Consistent with the presence of the prominent C-type lectin domain, several carbohydrate structures, including the sialyl Lewis X tetrasaccharide (sLex) (NeuAca2-3Gal~l-4(Fuca 1-3)GlcNAc), and the related structures VIM-2 (NeuAca2-3Gal~l-4G1cNAc~l-3Gal~l-4(FucaI-3)GlcNAc~l-3Gal), and FH6 (NeuAca2-3Galpl-4(Fuca l -3)GlcNAcP 1 -3GalP l-4(Fuca 1-3)GlcNAc), have been proposed to serve as E-selectin ligand^.^"^ Both sialylation and fucosylation appear to be essential components of E-selectin ligands. Addition of fucose may, in fact, be a regulatory step in the synthesis of E-selectin ligand(^).'^,'^ Creation of sLex requires addition of a fucose residue in an a1,3 linkage to a a-2,3-sialyllactosamine precursor, a reaction catalyzed by lineage-specific a1,3 fucosyltransferases. Only two of the seven cloned a 1,3 fucosyltransferases, FucT-VI1 and FucT-IV, are expressed at significant levels in normal leukocytes.'6"8 Interestingly, these two enzymes show alternate substrate specificities and activities. FucT-VI1 preferentially fucosylates a sialylated lactosamine precursor, whereas FucT-IV shows greater activity in modi- 
important in the initial steps of leukocyte extravasation into inflamed tissues. E-selectin binds neutrophils, monocytes, eosinophils, basophils, natural killer (NK) cells, and subsets of lymphocytes, although the precise ligand(s1 on these cells have not been identified. Several studies have proposed certain carbohydrate structures, including sLex and related structures, as E-selectin ligands. In contrast to these studies, we report here the identification of several human B cell lines that exhibit binding to E-selectin without expression of any of the previously identified E-selectin binding carbohydrate epitopes. The unique carbohydrate phenotype of these B cell lines suggests that they may express a novel,
-SELECTIN IS A cell adhesion molecule expressed by endothelial cells following activation by several inflammatory cytokines. ' .' E-selectin is one of a family of adhesion molecules, termed selectins, which contain C-type lectin domains and which share a similar domain structure and function."' E-and P-selectin are both inducibly expressed on endothelial cells lining blood vessels, while Lselectin is constitutively expressed on circulating leukocytes. Unlike P-selectin, which is rapidly mobilized to the cell surface by fusion of specialized storage granules with the plasma membrane, E-selectin surface expression occurs several hours after activation and requires de novo gene transcription and protein ~ynthesis.'.'.~ Binding of E-selectin to its ligand(s) results in leukocyte rolling along the lumenal surface of blood vessels,6 slowing movement enough to allow the secondary, higher affinity interactions involved in arrest of leukocytes on the endothelium. Interaction of selectins with their ligands characteristically shows Ca2+ dependence and sensitivity to neuraminidase treatment. E-selectin binds to ligand(s) present on several populations of leukocytes, including neutrophils, monocytes, eosinophils, basophils, natural killer (NK) cells, and some lymphocyte subpopulation~.~~'~~ Consistent with the presence of the prominent C-type lectin domain, several carbohydrate structures, including the sialyl Lewis X tetrasaccharide (sLex) (NeuAca2-3Gal~l-4(Fuca 1-3)GlcNAc), and the related structures VIM-2 (NeuAca2-3Gal~l-4G1cNAc~l-3Gal~l-4(FucaI-3)GlcNAc~l-3Gal), and FH6 (NeuAca2-3Galpl-4(Fuca l -3)GlcNAcP 1 -3GalP l-4(Fuca 1-3)GlcNAc), have been proposed to serve as E-selectin ligand^.^"^ Both sialylation and fucosylation appear to be essential components of E-selectin ligands. Addition of fucose may, in fact, be a regulatory step in the synthesis of E-selectin ligand(^).'^,'^ Creation of sLex requires addition of a fucose residue in an a1,3 linkage to a a-2,3-sialyllactosamine precursor, a reaction catalyzed by lineage-specific a1,3 fucosyltransferases. Only two of the seven cloned a 1,3 fucosyltransferases, FucT-VI1 and FucT-IV, are expressed at significant levels in normal leukocytes.'6"8 Interestingly, these two enzymes show alternate substrate specificities and activities. FucT-VI1 preferentially fucosylates a sialylated lactosamine precursor, whereas FucT-IV shows greater activity in modi- fying a neutral pre~ursor.'~*''.'~ Consistent with these enzymatic properties, FucT-IV forms Lewis X (Lex) but not sLex in transfected COS cells and most strains of CH0 cells, whereas FucT-VI1 forms sLex but not Lex.'&'' Given the requirement for sialic acid in formation of functional Eselectin ligand(s), and the stronger preference of FucT-VI1 for sialylated substrates, it is likely that FucT-VI1 plays a more important role than FucT-IV in leukocyte E-selectin ligand biosynthesis.
We were interested in investigating the role of cell surface carbohydrate phenotype and fucosyltransferase expression in generating functional E-selectin ligands on leukocytes. A panel of human hematopoietic cell lines was therefore examined for the ability to bind to E-selectin, for expression of carbohydrates implicated in E-selectin mediated adhesion, and for expression of FucT-IV and FucT-VII. Some of these cell lines bound to E-selectin, in a Ca" and neuraminidase sensitive manner, but failed to express any of the carbohydrate epitopes expected to be present on E-selectin binding cells. Analysis of a1,3 fucosyltransferase expression demonstrated a strong correlation of E-selectin ligand synthesis with expression of FucT-VII. Furthermore, transfection of FucT-VI1 cDNA conferred E-selectin binding in an otherwise nonbinding cell line. These data suggest that the ability of a cell line to bind to E-selectin correlates with its expression of FucT-VII, irrespective of surface carbohydrate phenotype.
MATERIALS AND METHODS
Cell lines and reagents. HL60, NALM-6, K562, HPB-ALL, BJAB, WTD, 73.3.4.2, LCL2, LCL3, and D-H10 were maintained at 37°C in RPMI 1640 (GIBCOBRL, Gaithersburg, MD), supplemented with 10% fetal calf serum (FCS), 1 % penicillin-streptomycin and 2 mmoVL glutamine. WTD, 73.3.4.2, LCL2, LCL3, and D-H10 are independently generated EBV-transformed B cell lines, and were the kind gift of R. Longnecker (Northwestern University). COS cells were maintained at 37°C in Dulbecco's modified essential medium (MEM) containing high glucose (GIBCO-BRL), supplemented with 10% Nu Serum, 1% penicillin-streptomycin, and 2 mmoVL glutamine. Carbohydrate IgM monoclonal antibodies (MoAbs) were obtained from various investigators, with specificities as follows: HECA-452 defines the CLA antigen, an sLex-like structure20. Nonsraric COS cell adhesion assays. Binding to E-selectin and P-selectin was determined in a rocking assay using transiently transfected COS cell^.^^.^^ Briefly, COS cells were transfected with cDNA encoding either E-selectin or P-selectin by the DEAE-dextran method in 100 mm tissue culture grade petri dishes. COS were replated into 35 mm dishes one day before the adhesion assay. Adhesion of cell lines to transfected COS cells was carried out at 4°C with constant rocking. Each plate of COS cells was washed twice with 2 mL RPMI 1640, followed by addition of a leukocyte cell suspension ( 2 X 10' cells in 0.6 mL). Cells were incubated at 4°C with rocking for 15 minutes, and the plates were then washed five times with 2 mL RPMI 1640 and fixed with ice cold 0.74% formaldehyde. Mean number of leukocytes bound per COS cell was determined by counting the number bound to approximately 100 COS cells in multiple fields of view. The number of leukocytes that bound per COS cell is a function of several variables, especially the available surface area of the COS cell, and the size of the leukocyte. As a control, in each experiment binding of other cell lines was compared with binding of the HL60 cell line, which has previously been shown to exhibit strong binding to both E-and P-selectin. Where indicated, adhesion assays were performed in the presence of 2.5 mmoVL EGTA (Sigma, St Louis, MO) or blocking MoAb, or after treatment of leukocytes with neuraminidase. For neuraminidase treatment, leukocytes were incubated at 37°C for I .5 hours with 0.2 U/mL C. perfringins neuraminidase (Sigma) in a total volume of 0.5 mL RPMI 1640, pH 5.9 before addition to COS cells. For EGTA and MoAb inhibition, leukocytes were suspended in 0.6 mL of RPMI containing either 0.25 mmoVL EGTA or a 1:200 dilution of E83 MoAb ascites, and COS cells were washed one time with RPMI, and once with RPMI containing either 0.25 mmoVL EGTA or E83 at 1:200, respectively, before addition of the cell suspension.
Flow cytometry analysis. For FACS analysis, 0.5 X lo6 cells were washed twice with RPMI 1640, and pellets were resuspended in 100 pL of primary MoAb at the following dilutions: purified HECA452 (8 ~g/mL), CSLEXl ascites (1:200), MMA ascites (1:1000), sLea ascites (l:lOO), VIM-2 ascites (1:250), FH6 tissue culture supernatant (undiluted), or isotype-matched control MoAb (8 pg/mL). Cells were incubated for 10 to 15 minutes at 4°C then washed once with I mL FACS Buffer (1% serum/O.l% NaN3/1 X PBS). Washed cells were resuspended in 100 pL of FITC-conjugated goat antimouse IgM (Biosource, Camarillo, CA), and incubated for I0 to 15 minutes at 4°C. Cells were washed with 1 mL FACS Buffer and resuspended in 0.5 mL FACS Buffer for flow cytometry. Flow cytometry was performed on a FACScan (Becton Dickinson, Bedford, MA). Data were collected using the CellQuest program to analyze a total of 10,000 light scatter gated events and plotted as histograms of log fluorescence intensity. FACS data represents the geometric mean of fluorescence intensity 2 standard deviation (SD).
RT-PCR. RNA was isolated from IO' cells using the TRIzol reagent (GIBCO/BRL) according to the manufacturer's protocol. RNA pellets were dissolved in DEPC H20, and contaminating genomic DNA was destroyed by incubation with IO U RNase-free DNase1 (Boehringer Mannheim, Indianapolis, IN) at 37°C for 15 minutes. RNA samples were stored at -80°C until use. Reverse transcription of 1 pg total cellular RNA was carried out in a total reaction volume of 20 pL containing 1 pg RNA, 10 mmoW DTT (GIBCO/BRL). 137 pmoVL random hexamer (Promega, Madison, Wl). I mmollL each dATP, dCTP, dGTP, and d l T P (Perkin-Elmer, Branchburg, NJ), 20 U RNAsin (Promega) in I X first strand buffer (GIBCOI BRL), and 200 U Superscript I1 RT (GIBCO/BRL) or 1 pL DEPC H' O (-RT control). Reverse transcription was carried out at 42°C for 1 hour, and samples were stored at -20°C. PCR reactions contained 1.5 mmol/L MgCl, (Perkin-Elmer), 0.2 mmol/L each dNTP, 0.5 pmol/L sense and antisense primer (GIBCO/BRL). and 2.5 U Taq polymerase (Perkin-Elmer) in 1 X PCR buffer (Perkin-Elmer), using 5 pL of the appropriate RT reaction as template for each PCR reaction. For detection of FucT-VI1 mRNA, the PCR protocol was: 1 minute at 9 4 T , I minute at 6 6 T , I minute at 72"C, for 36 cycles (Fig 4) or 40 cycles (Fig 5A) , using the sense primer 5'CCC ACC GTG GCC CAG TAC CGC TTC T-3' and the antisense primer 5'-CTG ACC TCT GTG CCC AGC CTC CCG T-3'. For FucT-IV detection, the PCR protocol was 1 minute at 9 4 T , I minute at 60"C, I minute at 72"C, for 30 cycles (Fig 4) or 40 cycles (Fig 5A) , using the sense primer 5'-CGG GTG TGC CAG GCT GTA CAG AGG-3' and the antisense primer 5'-TCG GGA ACA GTT GTG TAT GAG ATT-3'. For PGKl detection, either of the above protocols was used for 24 cycles (Fig 4) or 40 cycles (Fig 5A) , using the sense primer 5'-ATG ATT A7T GGT GGT GGA ATG GCT-3' and the antisense primer 5'-TCA TCC ATG AGA GCT TTG GTT CC-3'. FucT-VI1 primers amplify a product 500 bp long, with a unique, asymmetrical NueI site. FucT-IV primers amplify a product 480 bp long, with a uniyue, asymmetrical Ssp1 site. PGKl primers amplify a product 374 bp long. Presence of PCR products was assayed by gel electrophoresis in 1.4% agarose gel or by Southern blotting.
Suurhern blots. In order to make semiquantitative comparisons of RNA levels among various cell lines, PCR products from these cell lines were detected by Southern blot following gel electrophoresis. PCR cycles were titered for each primer set to ensure that products were analyzed in the linear (ie, pre-plateau) range of amplification. DNA was blotted onto nitrocellulose (Schleicher & Schuell, Keene, NH) using upward capillary transfer in 1OX SSC. Nitrocellulose filters were UV cross-linked, and prehybridization was carried out at 42°C for 2 to 3 hours in a solution of 5X SSPE, 5X Denhardt's, 1% sodium dodecyl sulfate (SDS), and 200 pg/mL denatured salmon sperm DNA. Radiolabeled probes were generated with the Random Primed DNA Labeling Kit (Boehringer Mannheim) according to the manufacturer's protocol, using either FucT-VI1 or FucT-IV cDNA or PGK 374 bp fragment (amplified from HL60 cell RNA as described above) as template. Hybridization was carried out at 42°C in a solution of 5 x SSPE, 5X Denhardt's, 50% formamide (USB, Cleveland, OH), 0.1% SDS, and 100 pg/mL denatured salmon sperm DNA, to which 10' cpm/mL of the appropriate probe was added. Following hybridization, blots were washed 2 times in 1 X SSPE, 
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FucT-VI1 cells were maintained in RPM1 1640, supplemented with 10% fetal calf serum (FCS), 1% penicillinlstreptomycin, and 2 mmol/L glutamine. FucT-VI1 mRNA was detected in the cloned transfectants by RT-PCR as described above.
RESULTS
NALM-6 cells bind well to E-selectin but not at all to Pselectin. In screening cell lines for their ability to bind to E-or P-selectin, we initially identified one cell line, NALM-6, which bound only to E-selectin. As shown in Fig IA, NALM-6 cells bound well to E-selectin transfected COS cells, but not at all to COS transfected with P-selectin cDNA. Control HL60 cells bound well to both selectins. Binding of NALM-6 cells to E-selectin transfected COS cells was inhibited by addition of the E-selectin MoAb, E83, or by addition of EGTA (Fig IB) . Binding was also inhibited by pretreatment of NALM-6 with neuraminidase, which suggests that E-selectin ligand function on NALM-6 cells requires the presence of sialic acid residues. Thus, binding to E-selectin by NALM-6 exhibited all of the hallmarks of a specific E-selectin-ligand interaction.
NALM-6 expresses a unique carbohydrate phenotype.
To determine whether NALM-6 cells expressed any of the expected carbohydrate antigens whose role in E-selectin interactions has previously been suggested, we performed flow cytometry using MoAb to several sialylated, fucosylated carbohydrates previously implicated in binding to E-selectin. Interestingly, we were unable to detect the presence of any of these known sialylated epitopes on NALM-6 by flow cytometry, although they were readily detectable on control HL60 cells. NALM-6 cells showed little or no staining with HECA452, which recognizes sLex and several related structures (Fig 2) , or with CSLEXI MoAb, which recognizes sLex (data not shown). NALM-6 cells were also negative for staining by VIM2 and FH6 MoAbs (data not shown). Unlike NALM-6, the HL60 control cell line stained brightly for all of these carbohydrate epitopes (Fig 2, and data not  shown) . Surprisingly, while untreated NALM-6 stained only weakly for Lex, treatment of NALM-6 with neuraminidase caused a substantial increase in staining by MMA (Fig 2) . This increase in staining indicates that the cleavage of sialic acid residues from the cell surface exposed Lex structures that had previously been masked by sialylation. These data suggest that NALM-6 cells express a novel sialoform of the Lewis X structure that is not recognized by the HECA452 or CSLEXl MoAbs, and which may serve as a ligand for E-selectin in this cell line.
Other B cell lines show similar characteristics to NAL" 6 with regard to E-selectin binding and carbohydrate phenotype. To identify other cell lines that exhibited binding characteristics similar to NALM-6, a panel of EBV-trans- The cell lines are indicated at the top, and are the same cell lines used for the adhesion assays (Fig 31. binding. In an effort to uncover the enzymatic basis of the binding phenotypes of different cell lines, the expression of a1,3 fucosyltransferases in this panel of cell lines was investigated. Of the seven cloned human a 1.3 fucosyltransferases, only FucT-VI1 and FucT-IV are expressed at significant levels in normal leukocytes. FucT-VI1 and FucT-IV expression in each cell line was determined semiquantitatively by RT-PCR, followed by Southern blotting of PCR products. Primers specific for phosphoglycerate kinase (PGKI), a housekeeping gene expressed at approximately the same relative level in all cells, were used as an internal control for reverse transcription. As shown in Fig 4, FucT-VI1 expression was detected in HL60. U937, NALM-6, WTD, 73.3.4.2, and LCL2, each of which bound E-selectin, but not in BJAB, K562, LCL3, and D-HI0 cells, which failed to bind E-selectin. In contrast, FucT-IV was expressed in all but one of these cell lines. whether or not they bound to E-selectin (Fig 4) . BJAB, which did not bind to E-or Pselectin, expressed neither FucT-IV nor FucT-VII. Although HPB-ALL, K562, LCL3, and D-HI0 cells each expressed FucT-IV but not FucT-V11, only HPB-ALL bound to Eselectin. This difference in adhesion phenotype between these cells may relate to the level of expression of FucT-IV, as HPB-ALL expressed mRNA for this enzyme at a much higher level than did the other cell lines (Fig 4) , or may be a function of other characteristics of the HPB-ALL cell line (see Discussion section). The strong association of FucT-VI1 expression with E-selectin binding ability supports an important role for this enzyme in the biosynthesis of functional E-selectin ligand(s).
E-selectin binding ability c m be conferred I~v transfection of FucT-VU DNA. The strong correlation of E-selectin binding with FucT-VI1 expression suggested that the expression of this enzyme might determine or be crucial for Eselectin ligand synthesis. K562 cells do not bind to E-or Pselectin (Fig 3) . and also fail to express FucT-VI1 (Fig 4) . Although K562 cells endogenously express FucT-IV (Fig   4) . expression of this enzyme at these levels in this cell line is not sufficient to permit E-selectin binding. To determine whether or not expression of FucT-VI1 would be sufficient to confer E-selectin binding ability, K562 cells were stably transfected with a plasmid encoding the FucT-VI1 cDNA. FucT-VI1 mRNA expression was easily detected by RT-PCR in cloned transfectants (Fig 5A) . In adhesion assays, K562/ FucT-VI1 transfectants bound well to E-selectin transfected COS cells (Fig 5B) . K562/FucT-VII transfectants also expressed high levels of CSLEXI and HECA-452 epitopes, while the nonbinding parent cell line did not (data not shown). This demonstrates that expression of FucT-VI1 alone is sufficient to confer E-selectin binding ability in K562 cells, while endogenous expression of FucT-IV is incapable of conferring this phenotype. These data strongly suggest that FucT-VI1 plays an important and direct regulatory role in the synthesis of E-selectin ligands.
DISCUSSION
To mount an effective immune response against invading pathogens, circulating immune cells must escape from the bloodstream and enter sites of infection and inflammation within tissues. Expression of selectins and their ligands is an important regulatory step in initiating leukocyte recruitment to sites of tissue injury. Although a precise biochemical description of selectin ligands is still lacking, it is clear that binding of selectins to their ligands requires appropriate glycosylation. including both sialylation and fuc~sylation."'.'.~~ In this study, we have examined the expression of fucosylated carbohydrates previously implicated in leukocyte adhesion mediated by E-selectin, and the role of CY 1.3 fucosyltransferases in determining E-selectin binding ability in a panel of human hematopoietic cell lines.
Analysis of surface carbohydrate phenotype with MoAb to carbohydrate epitopes previously associated with E-selectin binding showed no correlation with E-selectin ability. In particular, several B cell lines bound to E-selectin but did not express sLex or related structures that could be detected by existing MoAb. These cell lines, which bind to E-selectin but fail to express sLex, CLA, VIM2, or FH6, suggest the existence of a novel sialoform of LexiCDlS, which map serve as an E-selectin ligand in these cells. The E-selectin ligand expressed by these cells may represent an as yet undescribed form of sialylated CD15. Alternatively, it may res& from a unique modification of sialic acid residues on Lex, such as acetylation or sulfation, which subsequently masks the slex-like epitope from MoAbs. This modification may, in fact, be broadly characteristic of cells within the B cell lineage, as this sLex-negative carbohydrate phenotype was characteristic of both pre-B (NALM-6) and mature B (BJAB, WTD, LCLZ, 73.3.4.2) cell lines, but not of monocytic (U937, HL60) cell lines (Figs 3 and 4 , and data not shown).
WAGERS, LOWE, AND KANSAS
Although the expression of specific MoAb-defined carbohydrates does not appear to be required for adhesion to Eselectin, the data do suggest a major role for expression of CY 1,3 fucosyltransferases in specifying E-selectin ligand function. In cell lines that failed to express any of the typical carbohydrate epitopes associated with adhesion to E-selectin, binding to E-selectin showed a strong conelation with FucT-VI1 expression. All cell lines that expressed FucT-VIS bound to E-selectin. In addition, four out of five cell lines that failed to express FucT-VI1 failed to bind E-selectin, regardless of their expression of FucT-IV. FucT-IV was widely expressed by cell lines of several different lineages, and its expression did not correlate with E-selectin binding ability. Furthermore, transfection of FucT-VI1 cDNA was sufficient to confer E-selectin binding in K562 cells, while endogenous levels of FucT-IV were ineffective. Taken together, these data indicate that FucT-VI1 serves as the major regulator of E-selectin binding, while FucT-IV plays a more minor role in E-selectin ligand synthesis (see below). These observations are also consistent with biochemical data that have demonstrated alternate substrate specificities for FucT-IV and FucTsialylated precursor molecules, FucT-IV exhibits a strong preference for neutral substrates. Given the requirement for sialylation of functional E-selectin ligands, demonstrated by neuraminidase sensitivity, the preference of FucT-VI1 for sialylated substrates predicts that this enzyme would play a more important role in E-selectin ligand synthesis.
While all cells expressing FucT-VI1 at any detectable level bound to E-selectin, the T cell line HPB-ALL bound Eselectin but did not express FucT-VIS (Figs 3 and 4) . HPB-ALL cells also did not express FucT-111, -V, or -VI (data not shown), which can be expressed in cultured hematopoietic cell lines and which can also construct sLex and related carbohydrates. However, these cells expressed FucT-IV at relatively high levels, compared with the levels of FucT-IV expression by other cell lines (Fig 4) . These data suggest that the level of expression of FucT-IV may be important in determining its ability to generate functional E-selectin ligands. Consistent with our findings, Knibbs et a1 recently found that FucT-VI1 expression but not FucT-IV expression was closely and quantitatively correlated with sLex synthesis and adhesion to E-selectin in a variety of settings of T cell activation, but that overexpression of FucT-IV by transfection of a T lymphoblastoid cell line could also give detectable, albeit less efficient, interaction with E-selectin, without concomitant sLex expres~ion.'~ Alternatively, the ability of FucT-IV to construct E-selectin ligands may be a function of the glycosylation phenotype of the host ell.'^.^' Thus, certain strains of C H 0 cells express sLex and bind to Eselectin after transfection with FucT-IV, whereas COS cells and other strains of C H 0 cells do Similar variation is likely to occur across different leukocyte lineages, and among cultured hematopoietic cell lines. This may reflect the expression or relative abundance of distinct substrates for the different fucosyltransferases, or access to the substrate by different enzymes. Further work will be required to distinguish between these possibilities.
In this study, sLex+ and sLex-cell lines that express ~11.16.17,lY While FucT-VI1 shows a higher affinity for
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FucT-VI1 and bind to E-selectin were identified. This difference in surface carbohydrate phenotype may reflect quantitative differences in FucT-VI1 expression. Cells that express low levels of FucT-VI1 (such as Nalm-6, LCL2, 73.3.4.2, and WTD) were surface sLex-, while cells expressing high levels of FucT-VI1 (HL60, U937, and K562RucT-VII transfectants) were sLex+ (Fig 4, Table 1 , and data not shown). However, both cell types bind E-selectin (Figs 3 and 5B), indicating that lower levels of enzyme expression are sufficient to confer binding in the absence of surface sLex. A relatively high level of FucT-VI1 expression may be required for specifying surface sLex expression, while lower levels are sufficient for E-selectin binding ability. Thus, surface sLex expression may be indicative of high levels of FucT-VI1 activity, but is not required for E-selectin binding ability.
In summary, we have demonstrated an important role for the a 1,3 fucosyltransferase, FucT-VII, in construction of Eselectin ligand(s). In a panel of cell lines, expression of FucT-VI1 correlated closely with binding to E-selectin, whereas FucT-IV expression and cell surface carbohydrate phenotype did not. In addition, binding to E-selectin could be conferred by transfection with cDNA encoding FucT-VII. Expression of FucT-VI1 is likely to be important in determining whether leukocytes can leave the bloodstream and enter sites of inflammation. It will be interesting to determine the factors that regulate FucT-VI1 expression, as both differentiation and activation states may influence enzyme expression. It has already been demonstrated that sLex expression is altered by cell a~t i v a t i o n , '~.~~ and given the role of FucT-VI1 in generating this carbohydrate structure, it is likely that this enzyme will be regulated in parallel. In addition, FucT-VI1 may be important in developmental systems, where modulation of sLex expression has been shown to regulate migration of B cell progenitors into primary lymphoid Our data clearly suggest a significant role for FucT-VI1 activity in determining E-selectin ligand expression, and place this enzyme in an important position as a regulator of leukocyte traffic.
